196 related articles for article (PubMed ID: 11437678)
1. The prospect of treating rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.
Bresnihan B
BioDrugs; 2001; 15(2):87-97. PubMed ID: 11437678
[TBL] [Abstract][Full Text] [Related]
2. The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis.
Bresnihan B
Semin Arthritis Rheum; 2001 Apr; 30(5 Suppl 2):17-20. PubMed ID: 11357167
[TBL] [Abstract][Full Text] [Related]
3. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.
Bresnihan B; Alvaro-Gracia JM; Cobby M; Doherty M; Domljan Z; Emery P; Nuki G; Pavelka K; Rau R; Rozman B; Watt I; Williams B; Aitchison R; McCabe D; Musikic P
Arthritis Rheum; 1998 Dec; 41(12):2196-204. PubMed ID: 9870876
[TBL] [Abstract][Full Text] [Related]
4. [IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy].
Fiocco U; Vezzù M; Cozzi L; Todesco S
Reumatismo; 2004; 56(1 Suppl 1):62-73. PubMed ID: 15201942
[TBL] [Abstract][Full Text] [Related]
5. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
6. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores.
Jiang Y; Genant HK; Watt I; Cobby M; Bresnihan B; Aitchison R; McCabe D
Arthritis Rheum; 2000 May; 43(5):1001-9. PubMed ID: 10817552
[TBL] [Abstract][Full Text] [Related]
7. Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis.
Furst DE
Clin Ther; 2004 Dec; 26(12):1960-75. PubMed ID: 15823761
[TBL] [Abstract][Full Text] [Related]
8. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.
Cohen S; Hurd E; Cush J; Schiff M; Weinblatt ME; Moreland LW; Kremer J; Bear MB; Rich WJ; McCabe D
Arthritis Rheum; 2002 Mar; 46(3):614-24. PubMed ID: 11920396
[TBL] [Abstract][Full Text] [Related]
9. The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis.
Cunnane G; Madigan A; Murphy E; FitzGerald O; Bresnihan B
Rheumatology (Oxford); 2001 Jan; 40(1):62-9. PubMed ID: 11157143
[TBL] [Abstract][Full Text] [Related]
10. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.
Cohen SB; Moreland LW; Cush JJ; Greenwald MW; Block S; Shergy WJ; Hanrahan PS; Kraishi MM; Patel A; Sun G; Bear MB;
Ann Rheum Dis; 2004 Sep; 63(9):1062-8. PubMed ID: 15082469
[TBL] [Abstract][Full Text] [Related]
11. Anakinra as a new therapeutic option in rheumatoid arthritis: clinical results and perspectives.
Bresnihan B
Clin Exp Rheumatol; 2002; 20(5 Suppl 27):S32-4. PubMed ID: 14989427
[TBL] [Abstract][Full Text] [Related]
12. Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis.
Schiff MH
Ann Rheum Dis; 2000 Nov; 59 Suppl 1(Suppl 1):i103-8. PubMed ID: 11053099
[TBL] [Abstract][Full Text] [Related]
13. Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study Group.
Campion GV; Lebsack ME; Lookabaugh J; Gordon G; Catalano M
Arthritis Rheum; 1996 Jul; 39(7):1092-101. PubMed ID: 8670316
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
15. Treatment of rheumatoid arthritis patients with interleukin-1 receptor antagonist: radiologic assessment.
Watt I; Cobby M
Semin Arthritis Rheum; 2001 Apr; 30(5 Suppl 2):21-5. PubMed ID: 11357168
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of rheumatoid arthritis by interleukin-1 receptor antagonist].
Wendling D; Jorgensen C
Rev Med Interne; 2002 Dec; 23(12):1006-11. PubMed ID: 12504237
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.
Bendele A; McAbee T; Sennello G; Frazier J; Chlipala E; McCabe D
Arthritis Rheum; 1999 Mar; 42(3):498-506. PubMed ID: 10088773
[TBL] [Abstract][Full Text] [Related]
18. Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial.
Nuki G; Bresnihan B; Bear MB; McCabe D;
Arthritis Rheum; 2002 Nov; 46(11):2838-46. PubMed ID: 12428223
[TBL] [Abstract][Full Text] [Related]
19. [Interleukin-1 receptor antagonists in the treatment rheumatoid arthritis].
Zoń-Giebel A; Kotulska A; Giebel S; Cader SA; Kucharz EJ
Przegl Lek; 2002; 59(11):916-8. PubMed ID: 12715722
[TBL] [Abstract][Full Text] [Related]
20. Effects of DMARDs on IL-1Ra levels in rheumatoid arthritis: is there any evidence?
Cutolo M
Clin Exp Rheumatol; 2002; 20(5 Suppl 27):S26-31. PubMed ID: 14989426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
